Overview

  • Product name
    Valnoctamide
  • Description
    Noncompetitve arachidonic acid acylation inhibitor. Indirect GABA agonist.
  • Biological description
    Noncompetitve arachidonic acid acylation inhibitor (Ki = 6.38 mM). Indirect GABA agonist. Valproic acid (ab120745) derivative. Shows anticonvulsant effects in vivo.
  • Purity
    > 98%

Properties

References

This product has been referenced in:
  • Shekh-Ahmad T  et al. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential. Epilepsia 55:353-61 (2014). Read more (PubMed: 24313671) »
  • Spampanato J & Dudek FE Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus. Epilepsia 55:e94-8 (2014). Read more (PubMed: 24995528) »
  • Modi HR  et al. Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4. Bipolar Disord 16:875-80 (2014). Read more (PubMed: 25041123) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab146020.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up